Trial Search Results

Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)

The purpose of the study is to evaluate the overall and disease free survival of recipients who have received G-CSF mobilized stem cells from HLA matched sibling donors.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: Allogeneic hematopoietic cell transplantation

Eligibility


Inclusion Criteria:1. Any patient with one of the following hematologic malignancies in
whom an allogeneic stem cell transplant is warranted: Specific disease categories include:

   1. acute myelogenous leukemia, 1st or 2nd remission

   2. acute lymphoblastic leukemia, 1st or 2nd remission

   3. chronic myelogenous leukemia, 1st or 2nd CP, accelerated phase 2. Patient age > 1
   month and < 55 yo 3. Patients must have a genotypically HLA identical sibling 4.
   Patient must have adequate function as follows:

a. total bilirubin <2.5 and SGOT/SGPT <2x normal b. adequate renal function as defined by
creatinine < 1.5 or a 24 hr creatinine clearance >50 cc/min as determined by the
Cockroft-Gault formula (to be done if serum creatinine > 1.5) c. DLCO > 60% predicted d.
radionuclide cardiac scan with ejection fraction >45% 5. Patient must be competent to give
consent.

Inclusion criteria (Donor):

   1. HLA identical family member

   2. Donor or guardian must be competent to give consent

   3. Donor must have adequate veins for leukapheresis or agree to placement of central
   venous catheter

Exclusion Criteria:3.2 Exclusion Criteria (Patient):

   1. Evidence of active infection or active hepatitis

   2. Positive serologies for HIV-1,HIV-2 or hepatitis B surface ag+

   3. Previous allogeneic stem cell/bone marrow transplant

   4. Pregnant or lactating patients

4 Exclusion criteria (Donor):

   1. Donors who for psychologic, physiologic or medical reasons are unable to tolerate PBSC
   harvest

   2. Donors who are HIV+ or hepatitis B antigen +

   3. History of allergic reaction to G-CSF

   4. Female donors must be post-menopausal or have a negative pregnancy test

Ages Eligible for Study

N/A - 55 Years

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
BMT Referrals
6507230822
Not Recruiting